Beaulieu Joseph 4
4 · Epizyme, Inc. · Filed Mar 21, 2022
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Beaulieu Joseph
Corporate Controller
Transactions
- Award
Stock Option (Right to Buy)
2022-03-17+300,000→ 300,000 totalExercise: $1.39Exp: 2032-03-16→ Common Stock (300,000 underlying) - Award
Common Stock
2022-02-28$1.27/sh+2,331$2,952→ 30,963 total
Footnotes (2)
- [F1]These shares were acquired under the Company's 2013 Employee Stock Purchase Plan in a transaction that was exempt under both Rules 16b-3(d) and Rule 16b-3(c).
- [F2]This option was granted on March 17, 2022 pursuant to the Company's 2013 Stock Incentive Plan with respect to 300,000 shares of Common Stock, with 25% vesting on March 17, 2023 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.